USPTO serial 79293149
OLADAH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 22, 2021
- Examiner
- MILLER, JUSTIN T
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with OLADAH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Orchard Therapeutics (Europe) Limited
GB
Other trademarks owned by Orchard Therapeutics (Europe) Limited
Orchard Therapeutics (Europe) Limited
GB
Other trademarks owned by Orchard Therapeutics (Europe) Limited
Orchard Therapeutics (Europe) Limited
GB
Other trademarks owned by Orchard Therapeutics (Europe) Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rachel C. Santarlas
Rachel C. Santarlas Santarlas Law LLC641 Shunpike Road, #125CHATHAM, NJ 07928UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Chemical preparations for pharmaceutical or medical purposes for use in gene therapy for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders; Medicinal preparations for the treatment of orphan diseases, namely, inherited disorders of the immune system, inherited metabolic disorders, inherited blood disorders, inherited neuro-degenerative disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Orchard Therapeutics (Europe) Limited
- Other trademarks owned by Orchard Therapeutics (Europe) Limited
- Other trademarks owned by Orchard Therapeutics (Europe) Limited
- Other trademarks in Class 005
- Similar marks named OLADAH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 4, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 7, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 7, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 2, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 22, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 22, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 18, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 18, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 3, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 2, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 15, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 11, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 10, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |